Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.

Saved in:
Bibliographic Details
Title: Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Authors: Trifilio, S. M.1, Bennett, C. L.2,3, Yarnold, P. R.4, McKoy, J. M.5, Parada, J.6,7, Mehta, J.3, Chamilos, G.8, Palella, F.9, Kennedy, L.10, Mullane, K.7, Tallman, M. S.3, Evens, A.3, Scheetz, M. H.1, Blum, W.11, Kontoyiannis, D. P.12
Source: Bone Marrow Transplantation. Apr2007, Vol. 39 Issue 7, p425-429. 5p. 2 Charts.
Database: Academic Search Ultimate
Description
ISSN:02683369
DOI:10.1038/sj.bmt.1705614